LG Life Sciences said it has signed a contract with U.N. organizations for about $22 million worth of the vaccine, amounting to about half of the total hepatitis B vaccine distributed by the U.N. worldwide. Most of the vaccine, called Euvax-B, will be distributed over the next three years by the U.N.'s Children's Fund.

Related Summaries